Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SVF-003
- Development stage
- Unknown
- Lead developer
- SVF Vaccines
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular
01
Overview
SVF-003 is a prophylactic vaccine candidate developed by SVF Vaccines (Svenska Vaccinfabriken Produktion) utilizing a dual DNA and mRNA-based platform. It is designed to provide protection against both SARS-CoV-2 (the causative agent of COVID-19) and the Crimean-Congo Hemorrhagic Fever (CCHF) virus. The vaccine technology is engineered to induce a balanced immune response, stimulating both neutralizing antibody production and T-cell activation. SVF-003 is currently in Phase 1 clinical development, supported by the CCHF Vaccine consortium and funded by the European Commission, with research conducted in collaboration with the Karolinska Institutet.
02
Targets
Beyond the preview
Go deeper on SVF-003.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SVF-003.